ADVFN - Advanced Financial Network.
HOME» NYSE » A » ABT Stock Price » ABT Stock News

Abbott Labs Share News

 Abbott Laboratories Stock Price
ABT Stock Price
 Abbott Laboratories Stock Chart
ABT Stock Chart
 Abbott Laboratories Stock News
ABT Stock News
 Abbott Laboratories Company Information
ABT Company Information
 Abbott Laboratories Stock Trades
ABT Stock Trades

Abbott Buys AP214 Hormone From Action Pharma For $110 Million

DOW JONES NEWSWIRES Abbott Laboratories (ABT) took another step to enhance its renal-care pipeline by agreeing to acquire AP214, a hormone analogue that may prevent acute kidney injury during cardiac surgery, from Action Pharma A/S for $110 million in cash. The health-care company has been on a buying spree in recent years in order to reduce its dependence on the anti-inflammatory Humira as the drug's U.S. patent expires in late 2016. Abbott also is in the midst of separating into two publicly traded companies: a medical-products business and a pharmaceutical company to be named AbbVie. Abbott will acquire all global rights to develop and market AP214, and will be responsible for funding all future development and commercialization activities. No later milestone payments or royalties will be paid to the Danish biotech company Action Pharma. Abbott currently has two investigational treatments in development for chronic kidney disease: Bardoxolone, which is in Phase 3 development with Reata Pharmaceuticals, and Atrasentan, a compound discovered by Abbott being evaluated in a Phase 2b study. -By Melodie Warner, Dow Jones Newswires; 212-416-2283; melodie.warner@dowjones.com

Stock News for Abbott Labs (ABT)
DateTimeHeadline
03/30/201510:19:38The Best Stocks To Buy This Week
03/30/201508:38:10Abbott Labs Files to Sell Nearly a Third of Its Mylan Stake
03/28/201502:11:30Dividend Achievers Top 20 Hits The Mark, Again
03/27/201517:11:55Statement of Changes in Beneficial Ownership (4)
03/26/201508:36:34Mylan Is One Of The Most Undervalued Generic Companies
03/26/201503:20:53Top Large Cap Stocks That Investors Can Buy Now
03/17/201507:56:35The Best Stocks To Buy This Week
03/15/201514:00:00Abbott's MitraClip® System Shown to Mend Hearts and Improve...
03/15/201514:00:00Abbott's MitraClip® System Shown to Mend Hearts and Improve...
03/13/201517:30:53Statement of Changes in Beneficial Ownership (4)
03/13/201517:04:26Proxy Statement (definitive) (def 14a)
03/12/201517:33:31Statement of Changes in Beneficial Ownership (4)
03/10/201509:49:34Current Report Filing (8-k)
03/09/201505:48:27The Top Scoring Stocks To Buy This Week
03/06/201516:38:31Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
03/05/201517:25:30Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
03/05/201516:48:27Amended Current Report Filing (8-k/a)
03/05/201509:01:35Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
03/05/201508:34:17Automatic Shelf Registration Statement of Securities of Well-known...
03/05/201504:11:26Get Defensive With The Everyday American Portfolio

Abbott Laboratories and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad